Ursodeoxycholic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01586 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 99 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | homozygous familial hypercholesterolemia | KG + DL |
| 2 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 3 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 4 | pseudo-von Willebrand disease | KG + DL |
| 5 | primary release disorder of platelets | KG + DL |
| 6 | primary hyperoxaluria | KG + DL |
| 7 | diabetic nephropathy | KG + DL |
| 8 | Glanzmann thrombasthenia | KG + DL |
| 9 | obsolete familial combined hyperlipidemia | KG + DL |
| 10 | hypolipoproteinemia (disease) | KG + DL |
| 11 | serpinopathy with toxic serpin polymerization | KG + DL |
| 12 | immune-mediated necrotizing myopathy | KG + DL |
| 13 | familial apolipoprotein C-II deficiency | KG + DL |
| 14 | antisynthetase syndrome | KG + DL |
| 15 | thrombocytopenic purpura | KG + DL |
| 16 | C1 inhibitor deficiency | KG + DL |
| 17 | idiopathic eosinophilic myositis | KG + DL |
| 18 | inflammatory myopathy with abundant macrophages | KG + DL |
| 19 | focal myositis | KG + DL |
| 20 | sitosterolemia | KG + DL |
| 21 | hyperlipidemia | KG + DL |
| 22 | primary parathyroid hyperplasia | KG + DL |
| 23 | familial hyperlipidemia | KG + DL |
| 24 | familial hypercholesterolemia | KG + DL |
| 25 | hyperparathyroidism | KG + DL |
| 26 | HIV infectious disease | KG + DL |
| 27 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 28 | genetic otorhinolaryngological malformation | KG + DL |
| 29 | juvenile nasopharyngeal angiofibroma (disease) | KG + DL |
| 30 | cold agglutinin disease | KG + DL |
| 31 | familial nasal acilia | KG + DL |
| 32 | Ledderhose disease | KG + DL |
| 33 | glycogen storage disease due to phosphoglycerate kinase 1 deficiency | KG + DL |
| 34 | neonatal epileptic encephalopathy due to glutaminase deficiency | KG + DL |
| 35 | silent sinus syndrome | KG + DL |
| 36 | hypoglycemia | KG + DL |
| 37 | Norum disease | KG + DL |
| 38 | selective IgG immunodeficiency | KG + DL |
| 39 | idiopathic bilateral vestibulopathy | KG + DL |
| 40 | semicircular canal dehiscence syndrome | KG + DL |
| 41 | familial hypobetalipoproteinemia | KG + DL |
| 42 | proteinuria | KG + DL |
| 43 | primary CD59 deficiency | KG + DL |
| 44 | commissural lip fistula | KG + DL |
| 45 | hereditary angioedema with C1Inh deficiency | KG + DL |
| 46 | osteoradionecrosis of the mandible | KG + DL |
| 47 | oral leukoedema | KG + DL |
| 48 | burning mouth syndrome | KG + DL |
| 49 | infantile digital fibromatosis | KG + DL |
| 50 | branchial cleft anomaly | KG + DL |
(Showing top 50 of 99 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.